Saturday, 18 May 2013

Guidelines on the details of the various categories of variations Updated



The Commission has adopted the Guidelines on the details of the various categories of variations, on the operation of the procedures laid down in Chapters II, IIa, III and IV of Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products and on the documentation to be submitted pursuant to those procedures ("Guidelines").  
The Guidelines replace the Guideline on the operation of the procedures laid down in Chapters II, III and IV of Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products as well as the Guideline on the details of the various categories of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products.
The new Guidelines reflect the changes in the procedures for the variation of the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products introduced by Commission Regulation 712/2012. The Guidelines have also been updated with new classifications to reflect adaptation to technical progress, changes introduced in the basic legislation, and the experience acquired in the application of variation classifications.
The Guidelines will also be published in the Official Journal coinciding with the entry into force on 4 August 2013 of all changes introduced in Regulation 1234/2008 by Commission Regulation 712/2012.   The purpose of the earlier publication on our website is to enable marketing authorisation holders to make the necessary preparations so that the submission of variations can be done in accordance with the procedures and classifications explained in the Guidelines by 4 August 2013.

No comments:

Post a Comment